Regulation of Tfh cell differentiation and humoral immunity
Tfh细胞分化和体液免疫的调节
基本信息
- 批准号:10165471
- 负责人:
- 金额:$ 49.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-05 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibody AffinityAntibody ResponseAttenuatedAutoimmune DiseasesAutoimmunityB cell differentiationB-Cell DevelopmentB-LymphocytesBACH2 geneBLR1 geneCD4 Positive T LymphocytesCTLA4 geneCandidate Disease GeneCell CountCell DeathCell Differentiation processCellsChronicClinicalCommunicable DiseasesComplexDataDevelopmentFOXP1 geneGoalsHelper-Inducer T-LymphocyteHumoral ImmunitiesITIMImmune responseKineticsLeadMediatingMessenger RNAMolecularPathway interactionsPlayProliferatingReceptor Up-RegulationRegulationRoleSignal TransductionStructure of germinal center of lymph nodeT-Cell ActivationT-LymphocyteTranscriptional RegulationTumor stageVirus Diseaseschronic infectiondesignfunctional genomicsinfectious disease modelinfectious disease treatmentinsightnovelnovel markeroverexpressionprogrammed cell death protein 1public health relevancereceptorresponsetranscription factortreatment responsevaccine developmentvaccine trial
项目摘要
Project Summary
CD4+ T follicular helper (Tfh) cells are essential for germinal center (GC) responses and long-
term humoral immunity. However, the complex regulation that determines the differentiation of Tfh
cells, their developmental progression in GC, and their number and function in helping GC B cell
differentiation and antibody affinity selection, are still not fully understood. Our long-term goals are to
identify novel pathways underlying the differentiation of Tfh cells and design new strategies to
manipulate humoral responses for treatment of infectious diseases and autoimmune disorders and to
aid vaccine development.
Recently we have identified transcription factor Foxp1 as a rate-limiting and critical negative
regulator of Tfh cell differentiation, which drastically affects both the kinetics and the magnitude of the
antibody responses. Our new preliminary data now start to reveal that Foxp1 engages a complex
network of regulators that are coordinated to suppress Tfh cell differentiation as well as Tfh help to B
cells at different stages/steps of the GC response. In this application, we aim to identify Foxp1 targets
and elucidate the molecular mechanisms by which Foxp1 regulates Tfh cell differentiation. In addition,
we will further delineate how Foxp1-mediated regulation of Tfh cell differentiation affects GC B cell
development, antibody affinity selection and chronic infection. Our study will not only reveal new
components of the transcriptional regulation in Tfh cell differentiation, but also provide fundamental
mechanistic insights in the regulation of GC B cell responses and antibody affinity selection.
项目摘要
CD4+ T滤泡辅助器(TFH)细胞对于生发中心(GC)反应至关重要,并且很长
术语的体液免疫。但是,决定TFH分化的复杂调节
细胞,它们在GC中的发育进展以及它们在帮助GC B细胞中的数量和功能
分化和抗体亲和力选择仍未完全了解。我们的长期目标是
确定TFH细胞分化的基础的新型途径,并设计新策略
操纵体液反应以治疗传染病和自身免疫性疾病,并
辅助疫苗开发。
最近,我们将转录因子FOXP1确定为限制和临界负数
TFH细胞分化的调节剂,这极大地影响了动力学和大小
抗体反应。我们的新初步数据现在开始揭示FOXP1参与复杂
协调以抑制TFH细胞分化以及TFH有助于B的调节器网络
细胞处于GC响应的不同阶段/步骤。在此应用程序中,我们旨在确定FOXP1目标
并阐明FOXP1调节TFH细胞分化的分子机制。此外,
我们将进一步描述FOXP1介导的TFH细胞分化的调节如何影响GC B细胞
发育,抗体亲和力选择和慢性感染。我们的研究不仅会揭示新的
TFH细胞分化中转录调控的组成部分,但也提供基本
在调节GC B细胞反应和抗体亲和力选择的机理见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hui Hu其他文献
Hui Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hui Hu', 18)}}的其他基金
Transcriptional Regulation of CD4+ T Cell Differentiation and Diversified Memory
CD4 T 细胞分化和多样化记忆的转录调控
- 批准号:
10714458 - 财政年份:2023
- 资助金额:
$ 49.16万 - 项目类别:
Transcriptional Regulation of CD4+ T Cell Differentiation and Diversified Memory
CD4 T 细胞分化和多样化记忆的转录调控
- 批准号:
10741301 - 财政年份:2022
- 资助金额:
$ 49.16万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10645046 - 财政年份:2021
- 资助金额:
$ 49.16万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10523580 - 财政年份:2021
- 资助金额:
$ 49.16万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10214088 - 财政年份:2021
- 资助金额:
$ 49.16万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10414064 - 财政年份:2021
- 资助金额:
$ 49.16万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10771766 - 财政年份:2021
- 资助金额:
$ 49.16万 - 项目类别:
Transcriptional regulation of T cell quiescience and activation
T 细胞静止和激活的转录调控
- 批准号:
8872018 - 财政年份:2012
- 资助金额:
$ 49.16万 - 项目类别:
Negative regulatory pathways in T cell quiescence and T cell response
T 细胞静止和 T 细胞反应中的负调控途径
- 批准号:
8549950 - 财政年份:2012
- 资助金额:
$ 49.16万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:82273723
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
基于酵母展示与自体持续突变的纳米抗体快速亲和力成熟技术研究
- 批准号:82204046
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 49.16万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 49.16万 - 项目类别:
Optimization of protective antibodies response against bacterial adhesins
针对细菌粘附素的保护性抗体反应的优化
- 批准号:
10731509 - 财政年份:2023
- 资助金额:
$ 49.16万 - 项目类别:
Advancing Development of Novel Immunotherapy for Chemotherapy-induced Peripheral Neuropathy (CIPN)
推进化疗引起的周围神经病变 (CIPN) 的新型免疫疗法的发展
- 批准号:
10588384 - 财政年份:2023
- 资助金额:
$ 49.16万 - 项目类别: